HBIO
$3.84
Harvard Bioscience
($.16)
(4.00%)
HBIO
Earnings Whisper ®
N/A
4th Quarter December 2018
Consensus:  $0.05
Revenue:  $33.00 Mil
Thursday
Jan 24
4:00 PM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when HBIO reports earnings?
Beat
Meet
Miss

Where is HBIO's stock price going from here?
Up
Flat
Down
Stock chart of HBIO
Analysts
Summary of analysts' recommendations for HBIO
Score
Grade
Pivots
Resistance
-
-
-

-

Support
-
-
-
Tweet
Growth
Description
HARVARD BIOSCIENCE develops, manufactures and markets tools used in drug discovery research at pharmaceutical and biotechnology companies, universities and government laboratories.
Peers
IlluminaPerkinElmerAgilent TechnologiesCoherentBio-Rad LaboratoriesTranslate Bio